Sodium-Glucose Cotransporter-2 Inhibitor for Patients With Acute Cardiorenal Syndrome

This study is testing whether an SGLT2 inhibitor — a type of pill that lowers blood sugar and helps the kidneys and heart — can help patients with acute cardiorenal syndrome, a condition where both the heart and kidneys are failing at the same time. **You may be eligible if...** - You are between 18 and 85 years old - You have heart failure (either reduced or preserved pumping function) - You are experiencing a worsening of heart failure symptoms - You are able to take oral medication - You are willing to follow the study schedule **You may NOT be eligible if...** - You have type 1 diabetes - Your kidney function is severely impaired (very low eGFR) - You are in cardiogenic shock (heart failing so severely you need emergency intervention) - You are already on an SGLT2 inhibitor - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.